Parghane
RV
et al. Clinical utility of
177 Lu-DOTATATE PRRT in somatostatin receptor-positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity. Head Neck. 2020 Mar;42(3):401–16.
[PubMed: 31755622]